Impax Asset Management Group PLC Axonics, Inc. Transaction History

Impax Asset Management Group PLC

  • $23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024
BUY
$49.38 - $63.75 $1.48 Million - $1.91 Million
30,000 Added 13.98%
244,525 $15.2 Million
Q2 2023

Aug 07, 2023
BUY
$47.99 - $60.21 $4.08 Million - $5.12 Million
85,000 Added 65.62%
214,525 $10.8 Million
Q1 2023

May 10, 2023
BUY
$52.6 - $67.34 $6.81 Million - $8.72 Million
129,525 New
129,525 $7.07 Million

Others Institutions Holding AXNX

# of Institutions
221
Shares Held
42M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Impax Asset Management Group PLC Portfolio

Follow Impax Asset Management Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email